Published in Am J Physiol Heart Circ Physiol on May 15, 2009
Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging (2010) 1.63
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
The PGC-1 cascade as a therapeutic target for heart failure. J Mol Cell Cardiol (2010) 1.04
The mitochondrial uniporter controls fight or flight heart rate increases. Nat Commun (2015) 0.99
Creatine kinase overexpression improves ATP kinetics and contractile function in postischemic myocardium. Am J Physiol Heart Circ Physiol (2012) 0.89
Phenotyping of left and right ventricular function in mouse models of compensated hypertrophy and heart failure with cardiac MRI. PLoS One (2013) 0.87
An improved isolation procedure for adult mouse cardiomyocytes. Cell Biochem Biophys (2011) 0.86
Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol Cell Biol (2011) 0.82
Up-regulation of the cardiac lipid metabolism at the onset of heart failure. Cardiovasc Hematol Agents Med Chem (2011) 0.79
Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity. PLoS One (2013) 0.79
Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies. Oncotarget (2015) 0.78
Magnetic resonance imaging and spectroscopy of the murine cardiovascular system. Am J Physiol Heart Circ Physiol (2013) 0.77
Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study. PLoS One (2016) 0.75
In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations. NMR Biomed (2015) 0.75
A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition. Heart Fail Rev (2017) 0.75
The failing heart--an engine out of fuel. N Engl J Med (2007) 12.06
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med (1990) 2.18
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation (1995) 1.97
Phosphorus nuclear magnetic resonance of perfused working rat hearts. Nature (1977) 1.88
Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol (1982) 1.86
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet (1991) 1.82
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol (2002) 1.79
Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest (1993) 1.61
High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation (2001) 1.53
Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J (1991) 1.36
Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation (2005) 1.33
Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem (2000) 1.30
Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation (1999) 1.23
Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation (1982) 1.21
Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol Heart Circ Physiol (2006) 1.18
Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med (1996) 1.17
Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med (1990) 1.15
Luminometric assays of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP. Anal Biochem (1999) 1.11
Alterations in energy metabolism in cardiomyopathies. Ann Med (2007) 1.04
MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. Am J Physiol Heart Circ Physiol (2000) 0.99
Problems and expediencies in human 31P spectroscopy. The definition of localized volumes, dealing with saturation and the technique-dependence of quantification. NMR Biomed (1989) 0.95
Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol (2003) 0.93
Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med (1998) 0.91
Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy. Magn Reson Med (1999) 0.89
Calcineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol (2008) 0.86
Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure. Eur Heart J (1996) 0.85
Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium. MAGMA (2000) 0.85
In vivo 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction. Jpn Circ J (1992) 0.80
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol (1999) 17.45
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 2.99
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging (2008) 2.64
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging (2012) 2.62
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation (2008) 2.37
Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation (2006) 2.36
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA (1999) 2.12
Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol (2010) 2.09
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 1.94
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Quantitative cardiac 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med (2009) 1.83
Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci U S A (1987) 1.80
Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts. J Am Coll Cardiol (2012) 1.66
Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging (2010) 1.63
Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med (2002) 1.58
Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. Radiology (2008) 1.56
ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Circ Arrhythm Electrophysiol (2008) 1.55
Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol (1999) 1.51
Right, but not left, bundle branch block is associated with large anteroseptal scar. J Am Coll Cardiol (2013) 1.45
Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res (2001) 1.42
Comparative 13C and 31P NMR assessment of altered metabolism during graded reductions in coronary flow in intact rat hearts. Proc Natl Acad Sci U S A (1989) 1.41
Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort. Heart Rhythm (2013) 1.40
Magnetic resonance Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and sensitivity. J Magn Reson (2012) 1.37
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res (1990) 1.27
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol Heart Circ Physiol (2006) 1.18
Coronary magnetic resonance angiography. J Magn Reson Imaging (2007) 1.18
Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr) (2013) 1.18
Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation (2009) 1.13
Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med (2010) 1.09
Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med (2013) 1.08
Computational method for identifying and quantifying shape features of human left ventricular remodeling. Ann Biomed Eng (2009) 1.08
Measuring human cardiac tissue sodium concentrations using surface coils, adiabatic excitation, and twisted projection imaging with minimal T2 losses. J Magn Reson Imaging (2005) 1.08
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am J Physiol Heart Circ Physiol (2005) 1.04
On restoring motion-induced signal loss in single-voxel magnetic resonance spectra. Magn Reson Med (2006) 1.04
Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J (2005) 1.04
Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med (1999) 1.03
Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson (2013) 1.03
Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopy. J Magn Reson (2007) 0.99
Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ Res (1990) 0.97
Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest (1991) 0.96
Ca2+ transients in perfused hearts revealed by gated 19F NMR spectroscopy. Circ Res (1988) 0.95
Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study. Radiology (2008) 0.94
Indexing tricarboxylic acid cycle flux in intact hearts by carbon-13 nuclear magnetic resonance. Circ Res (1992) 0.94
Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin. Adv Enzyme Regul (2000) 0.94
Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol (2003) 0.93
Regional coronary endothelial function is closely related to local early coronary atherosclerosis in patients with mild coronary artery disease: pilot study. Circ Cardiovasc Imaging (2012) 0.92
An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB J (2002) 0.91
Oxygenation in the rabbit myocardium: assessment with susceptibility-dependent MR imaging. Radiology (1993) 0.91
Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One (2012) 0.89
Creatine kinase overexpression improves ATP kinetics and contractile function in postischemic myocardium. Am J Physiol Heart Circ Physiol (2012) 0.89
Energy state, pH, and vasomotor tone during hypoxia in precontracted pulmonary and femoral arteries. Am J Physiol Lung Cell Mol Physiol (2000) 0.88
Fatty acid regulation of glucose metabolism in the intact beating rat heart assessed by carbon-13 NMR spectroscopy: the critical role of pyruvate dehydrogenase. J Mol Cell Cardiol (1989) 0.87
Coronary artery distensibility assessed by 3.0 Tesla coronary magnetic resonance imaging in subjects with and without coronary artery disease. Am J Cardiol (2011) 0.87
In vivo 31P NMR spectroscopic changes during liver regeneration. J Surg Res (1990) 0.87
Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol (2010) 0.87
Tricarboxylic acid cycle activity in postischemic rat hearts. Circulation (1993) 0.87
Strain-encoding cardiovascular magnetic resonance for assessment of right-ventricular regional function. J Cardiovasc Magn Reson (2008) 0.87
Attenuated glycogenolysis reduces glycolytic catabolite accumulation during ischemia in preconditioned rat hearts. Circ Res (1996) 0.86
High-resolution proton NMR as indicator of a silent mutation in the haem cavity of a monomeric allosteric haemoglobin. Eur J Biochem (1983) 0.86
Non-invasive detection of coronary endothelial response to sequential handgrip exercise in coronary artery disease patients and healthy adults. PLoS One (2013) 0.85
Metabolic changes preceding functional and morphologic indices of rejection in heterotopic cardiac allografts. A 31P nuclear magnetic resonance study. Transplantation (1988) 0.85
Phase-sensitive black-blood coronary vessel wall imaging. Magn Reson Med (2010) 0.85
Myocardial energetics during ventricular fibrillation investigated by magnetization transfer nuclear magnetic resonance spectroscopy. Circ Res (1992) 0.85
Preservation of glucose metabolism in hypertrophic GLUT4-null hearts. Am J Physiol Heart Circ Physiol (2000) 0.85
Axial histidyl imidazole non-exchangeable proton resonances as indicators of imidazole hydrogen bonding in ferric cyanide complexes of heme peroxidases. Biochim Biophys Acta (1982) 0.84
Changes in high-energy phosphate metabolism and cell morphology in four models of acute experimental pancreatitis. Ann Surg (1991) 0.83
Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON). J Magn Reson Imaging (2008) 0.83
Role of preischemic glycogen depletion in the improvement of postischemic metabolic and contractile recovery of ischemia-preconditioned rat hearts. Circulation (1997) 0.82
Choline phospholipid metabolites of human vascular endothelial cells altered by cyclooxygenase inhibition, growth factor depletion, and paracrine factors secreted by cancer cells. Mol Imaging (2003) 0.82
Combined functional and viability cardiac MR imaging in a single breathhold. Magn Reson Med (2007) 0.81
Neurological grading, survival, MR imaging, and histological evaluation in the rat brainstem glioma model. Childs Nerv Syst (2008) 0.81
Gadolinium Enhanced MR Coronary Vessel Wall Imaging at 3.0 Tesla. Cardiol Res Pract (2010) 0.81
Consequences of altered aspartate aminotransferase activity on 13C-glutamate labelling by the tricarboxylic acid cycle in intact rat hearts. Biochim Biophys Acta (1995) 0.81
Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant (1990) 0.81
Effects of hypoxia on energy state and pH in resting pulmonary and femoral arterial smooth muscles. Am J Physiol (1998) 0.80
Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections. NMR Biomed (2013) 0.80
Spatially selective implementation of the adiabatic T2Prep sequence for magnetic resonance angiography of the coronary arteries. Magn Reson Med (2012) 0.80
Coronary MR imaging: lumen and wall. Magn Reson Imaging Clin N Am (2009) 0.80
Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy. Am J Cardiol (2013) 0.80
Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation (1989) 0.79
Use of 2D sensitivity encoding for slow-infusion contrast-enhanced isotropic 3-T whole-heart coronary MR angiography. AJR Am J Roentgenol (2011) 0.79
Cardiac Motion Analysis in Ischemic and Non-Ischemic Cardiomyopathy Using Parallel Transport. Proc IEEE Int Symp Biomed Imaging (2009) 0.79
High-energy phosphate transfer in human muscle: diffusion of phosphocreatine. Am J Physiol Cell Physiol (2011) 0.79
Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity. PLoS One (2013) 0.79
Left ventricular mechanical dyssynchrony by cardiac magnetic resonance is greater in patients with strict vs nonstrict electrocardiogram criteria for left bundle-branch block. Am Heart J (2013) 0.78
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease. J Cardiovasc Magn Reson (2005) 0.78
Direct evidence that coronary perfusion affects diastolic myocardial mechanical properties in canine heart. Cardiovasc Res (1993) 0.78
VESSEL CENTERLINE TRACKING AND BOUNDARY SEGMENTATION IN CORONARY MRA WITH MINIMAL MANUAL INTERACTION. Proc IEEE Int Symp Biomed Imaging (2012) 0.78
Robust volume-targeted balanced steady-state free-precession coronary magnetic resonance angiography in a breathhold at 3.0 Tesla: a reproducibility study. J Cardiovasc Magn Reson (2014) 0.78
Cine cardiac imaging using black-blood steady-state free precession (BB-SSFP) at 3T. J Magn Reson Imaging (2009) 0.78
Right coronary artery flow velocity and volume assessment with spiral K-space sampled breathhold velocity-encoded MRI at 3 tesla: accuracy and reproducibility. J Magn Reson Imaging (2010) 0.78
Exercise-induced decrease in myocardial high-energy phosphate metabolites in patients with Chagas heart disease. J Card Fail (2013) 0.77
Evidence from 31P nuclear magnetic resonance studies of cardiac allografts that early rejection is characterized by reversible biochemical changes. Transplantation (1989) 0.77
Coronary blood flow does not decrease during allograft rejection in heterotopic heart transplants. J Heart Lung Transplant (1991) 0.77